The promoter methylation rate was comparable across these melanoma types for tumor suppressors WIF1 (33–57%) and RASSF1 (44–51%); however, it was relatively lower in CMs (11%) compared to cutaneous and other mucosal melanomas (24–33%) for tumor suppressor PTEN. This evidence concerns the gene PTEN and melanoma.